Request for Covid-19 Impact Assessment of this Report
Market Segment as follows:
By Type
Fentanyl Transdermal Patch
Nicotine Transdermal Patch
Buprenorphine Transdermal Patch
Clonidine Transdermal Patch
Oxybutynin Transdermal Patch
Others
By Application
The fentanyl transdermal system (patch) is used for the management of persistent, moderate to severe chronic pain in opioid-tolerant patients when a continuous, around-the-clock opioid analgesic is needed for an extended period of time.
Nicotine skin patches are used to help people stop smoking cigarettes. They provide a source of nicotine that reduces the withdrawal symptoms experienced when smoking is stopped.
Buprenorphine patches are used to relieve severe pain in people who are expected to need pain medication around the clock for a long time and who cannot be treated with other medications. It is in a class of medications called opiate (narcotic) analgesics. It works by changing the way the brain and nervous system respond to pain.
Transdermal clonidine is used alone or in combination with other medications to treat high blood pressure. Clonidine is in a class of medications called centrally acting alpha-agonist hypotensive agents. It works by decreasing your heart rate and relaxing the blood vessels so that blood can flow more easily through the body.
Oxybutynin transdermal patches are used to treat an overactive bladder (a condition in which the bladder muscles contract uncontrollably and cause frequent urination, urgent need to urinate, and inability to control urination). Oxybutynin is in a class of medications called antimuscarinics. It works by relaxing the bladder muscles.
Others
By Company
Hisamitsu Pharmaceutical
Novartis
Johnson & Johnson
Teikoku Pharma
Mylan
Actavis
Mundipharma
Henan Lingrui Pharmaceutical
Changzhou Siyao
Rfl Pharmaceutical
The main contents of the report including:
Section 1:
Product definition, type and application, global and China market overview;
Section 2:
Global and China Market competition by company;
Section 3:
Global and China sales revenue, volume and price by type;
Section 4:
Global and China sales revenue, volume and price by application;
Section 5:
China export and import;
Section 6:
Company information, business overview, sales data and product specifications;
Section 7:
Industry chain and raw materials;
Section 8:
SWOT and Porter's Five Forces;
Section 9:
Conclusion.
1 Market Overview
1.1 Market Segment Overview
1.1.1 Product Definition
1.1.2 Market by Type
1.1.2.1 Fentanyl Transdermal Patch
1.1.2.2 Nicotine Transdermal Patch
1.1.2.3 Buprenorphine Transdermal Patch
1.1.2.4 Clonidine Transdermal Patch
1.1.2.5 Oxybutynin Transdermal Patch
1.1.2.6 Others
1.1.3 Market by Application
1.1.3.1 The fentanyl transdermal system (patch) is used for the management of persistent, moderate to severe chronic pain in opioid-tolerant patients when a continuous, around-the-clock opioid analgesic is needed for an extended period of time.
1.1.3.2 Nicotine skin patches are used to help people stop smoking cigarettes. They provide a source of nicotine that reduces the withdrawal symptoms experienced when smoking is stopped.
1.1.3.3 Buprenorphine patches are used to relieve severe pain in people who are expected to need pain medication around the clock for a long time and who cannot be treated with other medications. It is in a class of medications called opiate (narcotic) analgesics. It works by changing the way the brain and nervous system respond to pain.
1.1.3.4 Transdermal clonidine is used alone or in combination with other medications to treat high blood pressure. Clonidine is in a class of medications called centrally acting alpha-agonist hypotensive agents. It works by decreasing your heart rate and relaxing the blood vessels so that blood can flow more easily through the body.
1.1.3.5 Oxybutynin transdermal patches are used to treat an overactive bladder (a condition in which the bladder muscles contract uncontrollably and cause frequent urination, urgent need to urinate, and inability to control urination). Oxybutynin is in a class of medications called antimuscarinics. It works by relaxing the bladder muscles.
1.1.3.6 Others
1.2 Global and Regional Market Size
1.2.1 Global Overview
1.2.2 China Overview
2 Global and Regional Market by Company
2.1 Global
2.1.1 Global Sales by Company
2.1.2 Global Price by Company
2.2 China
2.2.1 China Sales by Company
2.2.2 China Price by Company
3 Global and Regional Market by Type
3.1 Global
3.1.1 Global Sales by Type
3.1.2 Global Price by Type
3.2 China
3.2.1 China Sales by Type
3.2.2 China Price by Type
4 Global and Regional Market by Application
4.1 Global
4.1.1 Global Sales by Application
4.1.2 Global Price by Application
4.2 China
4.2.1 China Sales by Application
4.2.2 China Price by Application
5 China Trade
5.1 Export
5.2 Import
6 Key Manufacturers
6.1 Hisamitsu Pharmaceutical
6.1.2 Company Information
6.1.2 Product Specifications
6.1.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
6.2 Novartis
6.2.1 Company Information
6.2.2 Product Specifications
6.2.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
6.3 Johnson & Johnson
6.3.1 Company Information
6.3.2 Product Specifications
6.3.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
6.4 Teikoku Pharma
6.4.1 Company Information
6.4.2 Product Specifications
6.4.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
6.5 Mylan
6.5.1 Company Information
6.5.2 Product Specifications
6.5.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
6.6 Actavis
6.6.1 Company Information
6.6.2 Product Specifications
6.6.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
6.7 Mundipharma
6.7.1 Company Information
6.7.2 Product Specifications
6.7.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
6.8 Henan Lingrui Pharmaceutical
6.8.1 Company Information
6.8.2 Product Specifications
6.8.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
6.9 Changzhou Siyao
6.9.1 Company Information
6.9.2 Product Specifications
6.9.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
6.10 Rfl Pharmaceutical
6.10.1 Company Information
6.10.2 Product Specifications
6.10.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
7 Industry Upstream
7.1 Industry Chain
7.2 Raw Materials
8 Market Environment
8.1 SWOT
8.2 Porter's Five Forces
9 Conclusion
Table Global Market Sales Revenue Share by Company 2013-2017
Table Global Market Sales Volume by Company 2013-2017
Table Global Market Sales Volume Share by Company 2013-2017
Table Global Price by Company 2013-2017
Table China Market Sales Revenue by Company 2013-2017
Table China Market Sales Revenue Share by Company 2013-2017
Table China Market Sales Volume by Company 2013-2017
Table China Market Sales Volume Share by Company 2013-2017
Table China Price by Company 2013-2017
Table Global Market Sales Revenue by Type 2013-2017
Table Global Market Sales Revenue Share by Type 2013-2017
Table Global Market Sales Volume by Type 2013-2017
Table Global Market Sales Volume Share by Type 2013-2017
Table Global Price by Type 2013-2017
Table China Market Sales Revenue by Type 2013-2017
Table China Market Sales Revenue Share by Type 2013-2017
Table China Market Sales Volume by Type 2013-2017
Table China Market Sales Volume Share by Type 2013-2017
Table China Price by Type 2013-2017
Table Global Market Sales Revenue by Application 2013-2017
Table Global Market Sales Revenue Share by Application 2013-2017
Table Global Market Sales Volume by Application 2013-2017
Table Global Market Sales Volume Share by Application 2013-2017
Table Global Price by Application 2013-2017
Table China Market Sales Revenue by Application 2013-2017
Table China Market Sales Revenue Share by Application 2013-2017
Table China Market Sales Volume by Application 2013-2017
Table China Market Sales Volume Share by Application 2013-2017
Table China Price by Application 2013-2017
Table China Export 2013-2017 (Value)
Table China Export 2013-2017 (Volume)
Table China Import 2013-2017 (Value)
Table China Import 2013-2017 (Volume)
Table Sales Revenue, Volume, Price, Cost and Margin of Hisamitsu Pharmaceutical
Table Sales Revenue, Volume, Price, Cost and Margin of Novartis
Table Sales Revenue, Volume, Price, Cost and Margin of Johnson & Johnson
Table Sales Revenue, Volume, Price, Cost and Margin of Teikoku Pharma
Table Sales Revenue, Volume, Price, Cost and Margin of Mylan
Table Sales Revenue, Volume, Price, Cost and Margin of Actavis
Table Sales Revenue, Volume, Price, Cost and Margin of Mundipharma
Table Sales Revenue, Volume, Price, Cost and Margin of Henan Lingrui Pharmaceutical
Table Sales Revenue, Volume, Price, Cost and Margin of Changzhou Siyao
Table Sales Revenue, Volume, Price, Cost and Margin of Rfl Pharmaceutical
List Of Figures
Figure Fentanyl Transdermal Patch Market Size and CAGR 2013-2017 (Value)
Figure Fentanyl Transdermal Patch Market Size and CAGR 2013-2017 (Volume)
Figure Fentanyl Transdermal Patch Market Forecast and CAGR 2018-2025 (Value)
Figure Fentanyl Transdermal Patch Market Forecast and CAGR 2018-2025 (Volume)
Figure Nicotine Transdermal Patch Market Size and CAGR 2013-2017 (Value)
Figure Nicotine Transdermal Patch Market Size and CAGR 2013-2017 (Volume)
Figure Nicotine Transdermal Patch Market Forecast and CAGR 2018-2025 (Value)
Figure Nicotine Transdermal Patch Market Forecast and CAGR 2018-2025 (Volume)
Figure Buprenorphine Transdermal Patch Market Size and CAGR 2013-2017 (Value)
Figure Buprenorphine Transdermal Patch Market Size and CAGR 2013-2017 (Volume)
Figure Buprenorphine Transdermal Patch Market Forecast and CAGR 2018-2025 (Value)
Figure Buprenorphine Transdermal Patch Market Forecast and CAGR 2018-2025 (Volume)
Figure Clonidine Transdermal Patch Market Size and CAGR 2013-2017 (Value)
Figure Clonidine Transdermal Patch Market Size and CAGR 2013-2017 (Volume)
Figure Clonidine Transdermal Patch Market Forecast and CAGR 2018-2025 (Value)
Figure Clonidine Transdermal Patch Market Forecast and CAGR 2018-2025 (Volume)
Figure Oxybutynin Transdermal Patch Market Size and CAGR 2013-2017 (Value)
Figure Oxybutynin Transdermal Patch Market Size and CAGR 2013-2017 (Volume)
Figure Oxybutynin Transdermal Patch Market Forecast and CAGR 2018-2025 (Value)
Figure Oxybutynin Transdermal Patch Market Forecast and CAGR 2018-2025 (Volume)
Figure Others Market Size and CAGR 2013-2017 (Value)
Figure Others Market Size and CAGR 2013-2017 (Volume)
Figure Others Market Forecast and CAGR 2018-2025 (Value)
Figure Others Market Forecast and CAGR 2018-2025 (Volume)
Figure The fentanyl transdermal system (patch) is used for the management of persistent, moderate to severe chronic pain in opioid-tolerant patients when a continuous, around-the-clock opioid analgesic is needed for an extended period of time. Market Size and CAGR 2013-2017 (Value)
Figure The fentanyl transdermal system (patch) is used for the management of persistent, moderate to severe chronic pain in opioid-tolerant patients when a continuous, around-the-clock opioid analgesic is needed for an extended period of time. Market Size and CAGR 2013-2017 (Volume)
Figure The fentanyl transdermal system (patch) is used for the management of persistent, moderate to severe chronic pain in opioid-tolerant patients when a continuous, around-the-clock opioid analgesic is needed for an extended period of time. Market Forecast and CAGR 2018-2025 (Value)
Figure The fentanyl transdermal system (patch) is used for the management of persistent, moderate to severe chronic pain in opioid-tolerant patients when a continuous, around-the-clock opioid analgesic is needed for an extended period of time. Market Forecast and CAGR 2018-2025 (Volume)
Figure Nicotine skin patches are used to help people stop smoking cigarettes. They provide a source of nicotine that reduces the withdrawal symptoms experienced when smoking is stopped. Market Size and CAGR 2013-2017 (Value)
Figure Nicotine skin patches are used to help people stop smoking cigarettes. They provide a source of nicotine that reduces the withdrawal symptoms experienced when smoking is stopped. Market Size and CAGR 2013-2017 (Volume)
Figure Nicotine skin patches are used to help people stop smoking cigarettes. They provide a source of nicotine that reduces the withdrawal symptoms experienced when smoking is stopped. Market Forecast and CAGR 2018-2025 (Value)
Figure Nicotine skin patches are used to help people stop smoking cigarettes. They provide a source of nicotine that reduces the withdrawal symptoms experienced when smoking is stopped. Market Forecast and CAGR 2018-2025 (Volume)
Figure Buprenorphine patches are used to relieve severe pain in people who are expected to need pain medication around the clock for a long time and who cannot be treated with other medications. It is in a class of medications called opiate (narcotic) analgesics. It works by changing the way the brain and nervous system respond to pain. Market Size and CAGR 2013-2017 (Value)
Figure Buprenorphine patches are used to relieve severe pain in people who are expected to need pain medication around the clock for a long time and who cannot be treated with other medications. It is in a class of medications called opiate (narcotic) analgesics. It works by changing the way the brain and nervous system respond to pain. Market Size and CAGR 2013-2017 (Volume)
Figure Buprenorphine patches are used to relieve severe pain in people who are expected to need pain medication around the clock for a long time and who cannot be treated with other medications. It is in a class of medications called opiate (narcotic) analgesics. It works by changing the way the brain and nervous system respond to pain. Market Forecast and CAGR 2018-2025 (Value)
Figure Buprenorphine patches are used to relieve severe pain in people who are expected to need pain medication around the clock for a long time and who cannot be treated with other medications. It is in a class of medications called opiate (narcotic) analgesics. It works by changing the way the brain and nervous system respond to pain. Market Forecast and CAGR 2018-2025 (Volume)
Figure Transdermal clonidine is used alone or in combination with other medications to treat high blood pressure. Clonidine is in a class of medications called centrally acting alpha-agonist hypotensive agents. It works by decreasing your heart rate and relaxing the blood vessels so that blood can flow more easily through the body. Market Size and CAGR 2013-2017 (Value)
Figure Transdermal clonidine is used alone or in combination with other medications to treat high blood pressure. Clonidine is in a class of medications called centrally acting alpha-agonist hypotensive agents. It works by decreasing your heart rate and relaxing the blood vessels so that blood can flow more easily through the body. Market Size and CAGR 2013-2017 (Volume)
Figure Transdermal clonidine is used alone or in combination with other medications to treat high blood pressure. Clonidine is in a class of medications called centrally acting alpha-agonist hypotensive agents. It works by decreasing your heart rate and relaxing the blood vessels so that blood can flow more easily through the body. Market Forecast and CAGR 2018-2025 (Value)
Figure Transdermal clonidine is used alone or in combination with other medications to treat high blood pressure. Clonidine is in a class of medications called centrally acting alpha-agonist hypotensive agents. It works by decreasing your heart rate and relaxing the blood vessels so that blood can flow more easily through the body. Market Forecast and CAGR 2018-2025 (Volume)
Figure Oxybutynin transdermal patches are used to treat an overactive bladder (a condition in which the bladder muscles contract uncontrollably and cause frequent urination, urgent need to urinate, and inability to control urination). Oxybutynin is in a class of medications called antimuscarinics. It works by relaxing the bladder muscles. Market Size and CAGR 2013-2017 (Value)
Figure Oxybutynin transdermal patches are used to treat an overactive bladder (a condition in which the bladder muscles contract uncontrollably and cause frequent urination, urgent need to urinate, and inability to control urination). Oxybutynin is in a class of medications called antimuscarinics. It works by relaxing the bladder muscles. Market Size and CAGR 2013-2017 (Volume)
Figure Oxybutynin transdermal patches are used to treat an overactive bladder (a condition in which the bladder muscles contract uncontrollably and cause frequent urination, urgent need to urinate, and inability to control urination). Oxybutynin is in a class of medications called antimuscarinics. It works by relaxing the bladder muscles. Market Forecast and CAGR 2018-2025 (Value)
Figure Oxybutynin transdermal patches are used to treat an overactive bladder (a condition in which the bladder muscles contract uncontrollably and cause frequent urination, urgent need to urinate, and inability to control urination). Oxybutynin is in a class of medications called antimuscarinics. It works by relaxing the bladder muscles. Market Forecast and CAGR 2018-2025 (Volume)
Figure Others Market Size and CAGR 2013-2017 (Value)
Figure Others Market Size and CAGR 2013-2017 (Volume)
Figure Others Market Forecast and CAGR 2018-2025 (Value)
Figure Others Market Forecast and CAGR 2018-2025 (Volume)
Figure Global Transdermal Patch Market Size and CAGR 2013-2017 (Value)
Figure Global Transdermal Patch Market Size and CAGR 2013-2017 (Volume)
Figure Global Transdermal Patch Market Forecast and CAGR 2018-2025 (Value)
Figure Global Transdermal Patch Market Forecast and CAGR 2018-2025 (Volume)
Figure China Transdermal Patch Market Size and CAGR 2013-2017 (Value)
Figure China Transdermal Patch Market Size and CAGR 2013-2017 (Volume)
Figure China Transdermal Patch Market Forecast and CAGR 2018-2025 (Value)
Figure China Transdermal Patch Market Forecast and CAGR 2018-2025 (Volume)
Figure Global Market Sales Revenue Share by Company in 2017
Figure Global Market Sales Volume Share by Company in 2017
Figure China Market Sales Revenue Share by Company in 2017
Figure China Market Sales Volume Share by Company in 2017
Figure Global Market Sales Revenue Share by Type in 2017
Figure Global Market Sales Volume Share by Type in 2017
Figure China Market Sales Revenue Share by Type in 2017
Figure China Market Sales Volume Share by Type in 2017
Figure Global Market Sales Revenue Share by Application in 2017
Figure Global Market Sales Volume Share by Application in 2017
Figure China Market Sales Revenue Share by Application in 2017
Figure China Market Sales Volume Share by Application in 2017
Figure Industry Chain Overview
Figure Transdermal Patch SWOT List
Figure Pharma & Healthcare Porter's Five Forces
The United States pneumococcal & meningococcal vaccines market is set to surpass US$ 7.5 Million by the year end of 2025. “United States Pneumococcal & Meningococcal Vaccines Market by Company Profile, Deals Type, Brand Analysis, Share, Key Trends & Opportunities to 2025” presents an in–depth assessment of the United States pneumococcal & meningococcal vaccines market dynamics, opportunitie...
The global human immunodeficiency virus (HIV) drugs market size is expected to surpass US$ 30 billion by 2025. “Global Human Immunodeficiency Virus (HIV) Drugs Market 2019 – 2025: Top 22 Drugs Analysis, Key Trends, Players and Forecasts” presents an in-depth assessment of the global human immunodeficiency virus (HIV) drugs market dynamics, opportunities, future roadmap, competitive landscap...
The global 50 blockbuster drugs market size is estimated to reach a value of US$ 292 billion by 2025. ‘’Global Blockbuster Drugs Market 2015 - 2025: Top 50 Drugs Analysis, Deal Trends, Players and Forecasts” presents an in-depth assessment of the global blockbuster drugs market dynamics, opportunities, future roadmap, competitive landscape and discusses major trends. The report offers the m...